Skip to main content

UBS Group AG

Position in GRAL — GRAIL, Inc.

CIK 1610520 ZURICH, V8

Position in GRAL

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$9,581,109
-$8,664,794 QoQ
Shares Held
185,393
-13.0% QoQ
Ownership
0.432%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority Sole 85.47733733204598.ToString("F0")% Shared 0.ToString("F0")% None 14.522662667954023.ToString("F0")%

Common Shares in GRAL Over Time

Shares Held

Position Value (USD)

Derivatives in GRAL

reported options exposure · as of Mar 31, 2026
CallValue
$583,984
CallShares
11,300
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,686,646,466 across 46 Diagnostics & Research names. GRAL ranks #21 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GRAL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $9,581,109 185,393
2026-03-31 $583,984 11,300
2025-12-31 $18,245,903 213,178
2025-12-31 $967,167 11,300
2025-09-30 $21,313,761 360,456
2025-06-30 $12,017,779 233,718
2025-03-31 $3,605,097 141,155
2024-12-31 $4,064,764 227,718
2024-09-30 $579,845 42,140
2024-06-30 $811,778 52,816